Syncope pp 79-105 | Cite as

Indications for and Interpretation of Laboratory Diagnostic Tests



The diagnostic evaluation strategy for patients with syncope of uncertain etiology (i.e., syncope that remains of uncertain nature after the initial evaluation) consists of either trying to formulate a diagnosis by employing selected laboratory tests or alternatively using a long-term monitoring approach until a syncope recurrence (or related event) can be documented (Table 7.1). In this chapter we describe the indication and the interpretation of the most commonly performed laboratory tests. In the next chapter (Chapter 8) we describe the indication and the interpretation of various systems for prolonged ECG monitoring.


Orthostatic Hypotension Carotid Sinus Structural Heart Disease Tilt Testing Vasovagal Syncope 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Thomas JE. Hyperactive carotid sinus reflex and carotid sinus syncope. Mayo Clin Proc. 1969;44:127–139.PubMedGoogle Scholar
  2. 2.
    Brignole M, et al. Guidelines on management (diagnosis and treatment) of syncope: Update 2004. Europace. 2004;6:467–537.PubMedCrossRefGoogle Scholar
  3. 3.
    Moya A, et al. Guidelines for the diagnosis and management of syncope (Version 2009). Eur Heart J. 2009;30:2631–2671.PubMedCrossRefGoogle Scholar
  4. 4.
    Kerr SR, et al. Carotid sinus hypersensitivity in asymptomatic older persons: implications for diagnosis of syncope and falls. Arch Intern Med. 2006;166:515–520.PubMedCrossRefGoogle Scholar
  5. 5.
    Puggioni E, et al. Results and complications of the carotid sinus massage performed according to the ‘methods of symptoms. Am J Cardiol. 2002;89:599–601.PubMedCrossRefGoogle Scholar
  6. 6.
    Brignole M, et al. Long-term outcome of paced and non paced patients with severe carotid sinus syndrome. Am J Cardiol. 1992;69:1039–1043.PubMedCrossRefGoogle Scholar
  7. 7.
    Claesson JE, et al. Less syncope and milder symptoms in patients treated with pacing for induced cardioinhibitory carotid sinus syndrome: a randomized study. Europace. 2007;9: 932–936.PubMedCrossRefGoogle Scholar
  8. 8.
    Menozzi C, et al. Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker. Am J Cardiol. 1993;72:1152–1155.PubMedCrossRefGoogle Scholar
  9. 9.
    Maggi R, et al. Cardioinhibitory carotid sinus hypersensitivity predicts an asystolic mechanism of spontaneous neurally-mediated syncope. Europace. 2007;9:563–567.PubMedCrossRefGoogle Scholar
  10. 10.
    Davies AG, Kenny RA. Neurological complications following carotid sinus massage. Am J Cardiol. 1998;81:1256–1257.PubMedCrossRefGoogle Scholar
  11. 11.
    Naschitz J, Rosner I. Orthostatic hypotension: Framework of the syndrome. Postgrad Med J. 2007;83:568–574.PubMedCrossRefGoogle Scholar
  12. 12.
    Ward C, Kenny RA. Reproducibility of orthostatic hypotension in symptomatic elderly. Am J Med. 1996;100:418–422.PubMedCrossRefGoogle Scholar
  13. 13.
    The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology. 1996;46(5):1470.CrossRefGoogle Scholar
  14. 14.
    Almquist A, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 1989;320:346–351.PubMedCrossRefGoogle Scholar
  15. 15.
    Benditt DG, et al. Tilt table testing for assessing syncope. ACC expert consensus document. J Am Coll Cardiol. 1996;28:263–275.PubMedCrossRefGoogle Scholar
  16. 16.
    Bartoletti A, et al. The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace. 2000;2:339–342.PubMedCrossRefGoogle Scholar
  17. 17.
    Brignole M, et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J. 2006;27:2232–2239.PubMedCrossRefGoogle Scholar
  18. 18.
    Flammang D, et al. Contribution of head-up tilt test and ATP testing in assessing the mechanisms of vasovagal syndrome: preliminary results and potential therapeutic implications. Circulation. 1999;99:2427–2433.PubMedCrossRefGoogle Scholar
  19. 19.
    Brignole M, et al. Adenosine-induced atrioventricular block in patients with unexplained syncope. The diagnostic value of ATP test. Circulation. 1997;96:3921–3927.PubMedCrossRefGoogle Scholar
  20. 20.
    Brignole M, et al. Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope. Heart. 2000;83:24–28.PubMedCrossRefGoogle Scholar
  21. 21.
    Saadjian A, et al. Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation. 2002;106:569–574.PubMedCrossRefGoogle Scholar
  22. 22.
    Brignole M, et al. Syncope due to idiopathic paroxysmal AV block: long-term follow-up of a distinct form of AV block. J Am Coll Cardiol. 2011(in press).Google Scholar
  23. 23.
    Benditt DG, et al. Indications for electrophysiological testing in diagnosis and assessment of sinus node dysfunction. Circulation. 1987; 75(suppl III):93–99.Google Scholar
  24. 24.
    Scheinman MM, et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol. 1982;50:1316–1322.PubMedCrossRefGoogle Scholar
  25. 25.
    Kaul U, et al. Evaluation of patients with bundle branch block and ”unexplained” syncope: a study based on comprehensive electrophysiologic testing and ajmaline stress. Pacing Clin Electrophysiol. 1988;11:289–297.PubMedCrossRefGoogle Scholar
  26. 26.
    Gaggioli G, et al. Progression to second or third-degree atrioventricular block in patients electrostimulated for bundle branch block: a long-term study. G Ital Cardiol. 1994;24:409–416.PubMedGoogle Scholar
  27. 27.
    Englund A, et al. Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and without syncope. J Am Coll Cardiol. 1995;26:1508–1515.PubMedCrossRefGoogle Scholar
  28. 28.
    Olshansky B, et al. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. Am Heart J. 1999;137:878–886.PubMedCrossRefGoogle Scholar
  29. 29.
    Link MS, et al. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular tachycardia. J Am Coll Cardiol. 1997;29:370–375.PubMedCrossRefGoogle Scholar
  30. 30.
    Pires L, et al. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillator. Am J Cardiol. 2000;85:725–728.PubMedCrossRefGoogle Scholar
  31. 31.
    Andrews N, et al. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 1999;34: 2023–2030.PubMedCrossRefGoogle Scholar
  32. 32.
    Brilakis E, et al. Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. Pacing Clin Electrophysiol. 2001;24:1623–1630.PubMedCrossRefGoogle Scholar
  33. 33.
    Kuck KH, et al. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J. 1988;9:177–185.PubMedGoogle Scholar
  34. 34.
    Corrado D, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–3091.PubMedCrossRefGoogle Scholar
  35. 35.
    Antzelevitch C, et al. Brugada syndrome: report of the second consensus conference: endorsed by the heart rhythm society and the European heart rhythm association circulation. 2005;111:659–670.Google Scholar
  36. 36.
    Paul M, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 2007;28:2126–2133.PubMedCrossRefGoogle Scholar
  37. 37.
    Sacher F, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation. 2006;114:2317–2324.PubMedCrossRefGoogle Scholar
  38. 38.
    Probst V, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation. 2010;121:635–643.PubMedCrossRefGoogle Scholar
  39. 39.
    Woeifel AK, et al. Exercise-induced distal atrio-ventricular block. J Am Coll Cardiol. 1983;2:578–582.CrossRefGoogle Scholar
  40. 40.
    Colivicchi F, et al. Exercise-related syncope in young competitive athletes without evidence of structural heart disease: clinical presentation and long-term outcome. Eur Heart J. 2002;23:1125–1130.PubMedCrossRefGoogle Scholar
  41. 41.
    Sakaguchi S, et al. Syncope associated with exercise, a manifestation of neurally mediated syncope. Am J Cardiol. 1995;75:476–481.PubMedCrossRefGoogle Scholar
  42. 42.
    Brignole M, et al. Prospective multicentre systematic guideline-based management of patients referred to the Syncope Units of general hospitals. Europace. 2010;12:109–118.PubMedCrossRefGoogle Scholar
  43. 43.
    Brignole M, et al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J. 2006;27:76–82.PubMedCrossRefGoogle Scholar
  44. 44.
    Croci F, et al. The application of a standardized strategy of evaluation in patients with syncope referred to three syncope units. Europace. 2002;4:357–360.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Dipartimento di Cardiologia, Centro AritmologicoOspedali del TigullioLavagnaItaly
  2. 2.Cardiac Arrhythmia CenterMedical School, University of MinnesotaMinneapolisUSA

Personalised recommendations